PUT - SPRINTER OPEN END - MODERNA Share Price

Certificat

DE000VU2UX61

Market Closed - Deutsche Boerse AG 18:53:37 14/06/2024 BST
5.05 EUR +15.56% Intraday chart for PUT - SPRINTER OPEN END - MODERNA
Current month+7.68%
1 month-17.48%
Date Price Change
14/06/24 5.05 +15.56%
13/06/24 4.37 +8.17%
12/06/24 4.04 -2.88%
11/06/24 4.16 -0.72%
10/06/24 4.19 +8.55%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 06:53 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MODERNA, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VU2UX6
ISINDE000VU2UX61
Date issued 30/01/2023
Strike 192.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.55
Lowest since issue 0.83

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
140 USD
Average target price
145.2 USD
Spread / Average Target
+3.67%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW